Welcome to the e-CCO Library!

P326: Efficacy of vedolizumab on patient-reported outcomes in ulcerative colitis patients: results from a prospective German observational study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Schmidt C.*1, Langbein C.1, Atreya R.2, Bruns T.1, Dignass A.3, Ende K.4, Hampe J.5, Hartmann F.3, Neurath M.F.2, Maul J.6,7, Preiss J.C.7, Schmelz R.5, Siegmund B.7, Schulze H.3, Teich N.8, van Arnim U.9, Baumgart D.C.10, Stallmach A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P326: Physicians’ recommendations for travel in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

W.P.W. Chan1,2, H.H. Shim2, S.C. Ng3, Asia–Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group, J. Liu1, C. Inglis1, K. Greveson4, R.W. Leong1*

Created: Thursday, 21 February 2019, 9:14 AM
P326: PREFAB-study: PRediction tool for Early identification of patients at risk of Crohn's disease in perianal Fistulas and ABscesses: interim analysis of a prospective pilot study at a non-academic, IBD-expert centre in the Netherlands
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Munster, L.(1)*;de Groof, E.J.(1);van Dieren, S.(2);Mundt, M.W.(3);D'Haens, G.R.A.M.(4);Bemelman, W.A.(5);Buskens, C.J.(5);van der Bilt, J.D.W.(1);
Created: Friday, 14 July 2023, 11:05 AM
P326: The effect of compliance during exclusive enteral nutrition on faecal calprotectin levels in children with Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Mckirdy, S.(1);Russell, R.(2);Hansen, R.(3);Svolos, V.(1);Gkikas, K.(1);Logan, M.(1);Gerasimidis, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P326: Validation of CUCQ-8 Questionnaire for Quality of Life Assessment in IBD Patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

C. McGinley*1, C. Mowat2, M. Groome2, J. Todd2, N. Reynolds2

Created: Friday, 22 February 2019, 9:49 AM
P327 Effectiveness of anti-TNF vs. vedolizumab as a second biologic in IBD: results from national Swedish registers
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Rundquist1, M. Sachs2, C. Eriksson1, O. Olén3, S. Montgomery4, J. Halfvarson1, SWIBREG Study Group

Created: Thursday, 30 January 2020, 10:12 AM
P327: Biosimilar infliximab in real-life Crohn’s disease’s anti-TNFalfa naïve patients: a comparative observational cohort study (SIMRECRO study)
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Carvalho Lourenço*, V. Anapaz, A. M. Oliveira, J. Branco, M. Cardoso, C. Graça Rodrigues, L. Santos, D. Horta, A. Martins, J. Reis

Created: Friday, 22 February 2019, 9:49 AM
P327: Characteristics of esophago-gastro-duodenal Crohn's disease in the biologic era: a nationwide study of the Young GETECCU Group
Year: 2023
Source: ECCO’23 Copenhagen
Authors: López García, A.(1)*;Benítez, J.M.(2);Maroto-Martín, C.(3);Fernández-Prada, S.J.(3);Marquina, V.(4);Rodríguez, G.E.(5);Mesonero, F.(6);Lucendo, A.J.(7);Flórez-Díez, P.(8);Casanova, M.J.(9);García-Morales, N.(10);Miranda, J.(11);Vicuña, M.(12);Font, G.(1);Suárez-Ferrer, C.(13);Bernal, L.(14);Peries, L.(15);Mínguez, A.(16);Tejedor, J.(17);Pérez-Galindo, P.(18);Elosua, A.(19);Lastiri, E.A.(20);Brunet, E.(21);Llaó, J.(22);Rodríguez-Lago, I.(23);Ferreiro-Iglesias, R.(24);López, L.(25);González, I.(26);Ortega, S.P.(27);Monsalve, S.(28);Márquez-Mosquera, L.(1);González-Vivó, M.(1);Murciano, F.(1);Zabana, Y.(4);Barreiro-de Acosta, M.(24);
Created: Friday, 14 July 2023, 11:05 AM
P327: Comparison of adalimumab drug levels and drug survival in proactive vs reactive therapeutic drug monitoring
Year: 2022
Source: ECCO'22
Authors: Shields, S.(1);Dunlop, A.(2);Barry, S.(3);Galloway, P.(2);Seenan, J.P.(1);Macdonald, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P327: Evolution after a “de-intensification” strategy with anti-TNF therapy in patients with inflammatory bowel disease in clinical remission: multicenter study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Benítez J.M.*1, Barreiro-de Acosta M.2, Chaparro M.3, Vázquez J.M.4, Iglesias-Flores E.1, Tosca J.5, García-Planella E.6, García-Lόpez S.7, Taxonera C.8, Muñoz-Villafranca M.9, Pajares R.10, Barrio J.11, Arias L.12, Nantes O.13, Fernández-Salazar L.14, Hervías D.15, Martín-Arranz M.16, Mesonero F.17, Moraleja-Yudejo I.18, Pineda J.19, Argüelles-Arias F.20, Huguet J.21, Hernández-Martínez A.22, Pérez-Calle J.23, Leo E.24, Merino O.25, Van Domselaar M.26, Gutiérrez A.27, Lorente R.28, Castro M.29, Algaba A.30, Castro E.31, Robles-Alonso V.32, Ceballos D.33, Gόmez-García R.34, Domínguez J.35, Fernández E.36, Vega-Lόpez A.37, Trapero A.38, Talavera A.39, Royo V.40, Gisbert J.P.3, García-Sánchez V.1

Created: Wednesday, 20 February 2019, 10:36 AM
P327: Long-term effectiveness of ustekinumab in refractory Crohn's disease: an Italian multicenter real-life study
Year: 2021
Source: ECCO'21 Virtual
Authors: Scribano, M.L.(1);Aratari, A.(2);Neri, B.(3);Bezzio, C.(4);Balestrieri, P.(5);Falasco, G.(1);Camastra, C.(1);Pantanella, P.(1);Monterubbianesi, R.(1);Tullio, A.(5);Saibeni, S.(4);Papi, C.(2);Biancone, L.(3);Cosintino, R.(1);Faggiani, R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P327: Segmental colectomy for ulcerative colitis: a new paradigm? A multi-centric study in 72 patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Frontali*1, Y. Panis1, L. Cohen2, V. Bridoux3, P. Myrelid4, G. Sica5, G. Poggioli6, E. Espin7, L. Beyer-Berjot8, D. Laharie9, A. Spinelli10, P. Zerbib11, G. Sampietro12, M. Frasson13, E. Louis14, X. Treton2

Created: Friday, 22 February 2019, 9:41 AM
P327: Symptom relevance attributed by inflammatory bowel disease patients has a differential impact on their quality of life
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Casellas*, C. Herrera de Guise, V. Robles, E. Navarro, M. Guirola, N. Borruel

Created: Thursday, 21 February 2019, 9:14 AM
P328 Faecal microbiota transplantation as treatment for recurrent Clostridiodes difficile infection in patients with inflammatory bowel disease: Experiences of the Netherlands donor faeces bank
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Van Lingen1, A.E. van der Meulen-de Jong1, K.E.W. Vendrik2, E.J. Kuijper2, E.M. Terveer2, J.J. Keller3

Created: Thursday, 30 January 2020, 10:12 AM
P328: Crohn’s colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Krishnaprasad1,2*, A. Walsh3, J. Begun4, S. Bell2, D. Carter5, R. Grafton6, A. Sechi7, K. Sewell8, A. McMahon8, S. Connor7, G. Radford-Smith1,8,9, J. Andrews6,10, ANZIBD Consortium, Crohn's Colitis Cure

Created: Thursday, 21 February 2019, 9:14 AM
P328: Factors related to short- and long-term treatment results and usefulness of infliximab for refractory ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Takada*, S. Yasukawa, R. Amano, M. Yasaka, N. Takatsu, Y. Yano, F. Hirai

Created: Friday, 22 February 2019, 9:49 AM
P328: Holistic well-being as Patient-reported outcomes (PROs) in translational IBD research: Prospective capture of CUCQ32 as study endpoints for mechanistic biomarker MUSIC/GIDAMPs study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hall, R.(1)*;Chuah, C.S.(1);Brownson, E.(2);Poulose, B.(1);Athena, O.(1);Mowat, C.(3);Macdonald, J.(2);Seenan, J.P.(2);Ho, G.T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P328: In silico evaluation and pre-clinical efficacy of anti-TNF and anti-IL-23 combination therapy in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Perrigoue, J.(1);Muniz-Bongers, L.(1);Ong, L.(1);Chen, Y.(2);Chang, L.(2);Ngo, K.(2);Stojmirovic, A.(1);O’Brien, C.(1);Germinaro, M.(1);Rao, R.(1);Vetter, M.(1);Towne, J.(2);
Created: Friday, 11 February 2022, 3:52 PM
P328: Low vitamin K, vitamin D and calcium dietary intake in IBD patients represents a potentially reversible risk factor for osteoporosis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. S. Bertetti1, G. Burrelli Scotti1, M. T. Afferri1, V. Casali1, E. Cuofano1, C. Tortoriello1, A. De Carolis1, P. Vernia*1

Created: Friday, 22 February 2019, 9:41 AM